Top Markets
Coin of the day
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Rankning i aktier #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Aktiekurs
$0.78611575
Marknadsvärde
$60.45M
Förändring (1 dag)
0.00%
Förändring (1 år)
-12.06%
Land
NO
Handel Lytix Biopharma AS (LYTIX)

Kategori

Historik för aktiesplit för Lytix Biopharma AS (LYTIX)
Aktien Lytix Biopharma AS (symbol: LYTIX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 21, 2026.
En LYTIX-aktie köpt före Aug 21, 2026 motsvarar nu 0 LYTIX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH